Scott C. Jeffrey

2.4k total citations
33 papers, 1.6k citations indexed

About

Scott C. Jeffrey is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Scott C. Jeffrey has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 23 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Molecular Biology. Recurrent topics in Scott C. Jeffrey's work include Monoclonal and Polyclonal Antibodies Research (22 papers), HER2/EGFR in Cancer Research (21 papers) and Glycosylation and Glycoproteins Research (9 papers). Scott C. Jeffrey is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (22 papers), HER2/EGFR in Cancer Research (21 papers) and Glycosylation and Glycoproteins Research (9 papers). Scott C. Jeffrey collaborates with scholars based in United States and New Zealand. Scott C. Jeffrey's co-authors include Peter D. Senter, Nicole M. Okeley, Dennis R. Benjamin, Stephen C. Alley, Damon L. Meyer, Patrick Burke, Russell J. Sanderson, Jamie B. Miyamoto, Ivan J. Stone and Robert P. Lyon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Blood.

In The Last Decade

Scott C. Jeffrey

32 papers receiving 1.6k citations

Peers

Scott C. Jeffrey
Martha E. Anderson United States
Robert P. Lyon United States
Roger F. Zabinski United States
Tim D. Bovee United States
Jamie B. Miyamoto United States
Brian A. Mendelsohn United States
Michael Torgov United States
Shang‐Fan Yu United States
Brian E. Toki United States
Janis Upeslacis United States
Martha E. Anderson United States
Scott C. Jeffrey
Citations per year, relative to Scott C. Jeffrey Scott C. Jeffrey (= 1×) peers Martha E. Anderson

Countries citing papers authored by Scott C. Jeffrey

Since Specialization
Citations

This map shows the geographic impact of Scott C. Jeffrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott C. Jeffrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott C. Jeffrey more than expected).

Fields of papers citing papers by Scott C. Jeffrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott C. Jeffrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott C. Jeffrey. The network helps show where Scott C. Jeffrey may publish in the future.

Co-authorship network of co-authors of Scott C. Jeffrey

This figure shows the co-authorship network connecting the top 25 collaborators of Scott C. Jeffrey. A scholar is included among the top collaborators of Scott C. Jeffrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott C. Jeffrey. Scott C. Jeffrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryan, Maureen C., Ryan A. Heiser, Jessica K. Simmons, et al.. (2020). SGN-CD30C, an Investigational CD30-Directed Camptothecin Antibody-Drug Conjugate (ADC), Shows Strong Anti Tumor Activity and Superior Tolerability in Preclinical Studies. Blood. 136(Supplement 1). 41–42. 3 indexed citations
2.
Courter, Joel R., Andrew B. Waight, Robert P. Lyon, et al.. (2020). Structure-activity relationships of tubulysin analogues. Bioorganic & Medicinal Chemistry Letters. 30(14). 127241–127241. 10 indexed citations
3.
Burke, Patrick, Holden W. H. Lai, Kim K. Emmerton, et al.. (2018). Glucuronide-Linked Antibody–Tubulysin Conjugates Display Activity in MDR+ and Heterogeneous Tumor Models. Molecular Cancer Therapeutics. 17(8). 1752–1760. 15 indexed citations
4.
Burke, Patrick, Joshua H. Hunter, Julia H. Cochran, et al.. (2017). Abstract 56: Antibody-drug conjugates containing glucuronide-tubulysin payloads display activity in MDR+ and heterogeneous tumor models. Cancer Research. 77(13_Supplement). 56–56. 1 indexed citations
5.
Burke, Patrick, Scott C. Jeffrey, Joshua H. Hunter, et al.. (2016). Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 16(1). 116–123. 110 indexed citations
6.
Burke, Patrick, Jocelyn R. Setter, Joshua H. Hunter, et al.. (2016). Development of Novel Quaternary Ammonium Linkers for Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 15(5). 938–945. 45 indexed citations
7.
Kolakowski, Robert V., Kim K. Emmerton, Chris Leiske, et al.. (2016). The Methylene Alkoxy Carbamate Self‐Immolative Unit: Utilization for the Targeted Delivery of Alcohol‐Containing Payloads with Antibody–Drug Conjugates. Angewandte Chemie. 128(28). 8080–8083. 8 indexed citations
8.
Kolakowski, Robert V., Kim K. Emmerton, Chris Leiske, et al.. (2016). The Methylene Alkoxy Carbamate Self‐Immolative Unit: Utilization for the Targeted Delivery of Alcohol‐Containing Payloads with Antibody–Drug Conjugates. Angewandte Chemie International Edition. 55(28). 7948–7951. 56 indexed citations
9.
Kolakowski, Robert V., Thomas D. Young, Philip W. Howard, Scott C. Jeffrey, & Peter D. Senter. (2015). Synthesis of a C2-aryl-pyrrolo[2,1-c][1,4]benzodiazepine monomer enabling the convergent construction of symmetrical and non-symmetrical dimeric analogs. Tetrahedron Letters. 56(30). 4512–4515. 17 indexed citations
10.
Okeley, Nicole M., Stephen C. Alley, Martha E. Anderson, et al.. (2013). Development of orally active inhibitors of protein and cellular fucosylation. Proceedings of the National Academy of Sciences. 110(14). 5404–5409. 147 indexed citations
11.
Sutherland, May S.K., Roland B. Walter, Scott C. Jeffrey, et al.. (2013). SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML. Blood. 122(8). 1455–1463. 291 indexed citations
12.
Sutherland, May S.K., Roland B. Walter, Scott C. Jeffrey, et al.. (2012). SGN-CD33A: A Novel CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Preclinical Antitumor Activity Against Multi-Drug Resistant Human AML. Blood. 120(21). 3589–3589. 7 indexed citations
13.
Jeffrey, Scott C., Patrick Burke, David W. Meyer, et al.. (2012). Abstract 4631: Anti-CD70 antibody-drug conjugates containing pyrrolobenzodiazepine dimers demonstrate robust antitumor activity. Cancer Research. 72(8_Supplement). 4631–4631. 1 indexed citations
14.
Jeffrey, Scott C., Jef K. De Brabander, Jamie B. Miyamoto, & Peter D. Senter. (2010). Expanded Utility of the β-Glucuronide Linker: ADCs That Deliver Phenolic Cytotoxic Agents. ACS Medicinal Chemistry Letters. 1(6). 277–280. 44 indexed citations
15.
Burke, Patrick, Brian E. Toki, David W. Meyer, et al.. (2009). Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system. Bioorganic & Medicinal Chemistry Letters. 19(10). 2650–2653. 20 indexed citations
16.
White, James D. & Scott C. Jeffrey. (2009). Synthesis of the northern sector (C8–C19) of rapamycin via Chan rearrangement and oxidation of an α-acyloxyacetate. Tetrahedron. 65(33). 6642–6647. 6 indexed citations
17.
Jeffrey, Scott C., et al.. (2007). Minor groove binder antibody conjugates employing a water soluble β-glucuronide linker. Bioorganic & Medicinal Chemistry Letters. 17(8). 2278–2280. 41 indexed citations
18.
Alley, Stephen C., Nicole M. Okeley, Russell J. Sanderson, et al.. (2006). Intracellular metabolism of antibody-drug conjugates: identification and quantitation of released drugs. Cancer Research. 66. 469–469. 3 indexed citations
19.
Jeffrey, Scott C., Minh T. Nguyen, Jamie B. Andreyka, et al.. (2005). Dipeptide-based highly potent doxorubicin antibody conjugates. Bioorganic & Medicinal Chemistry Letters. 16(2). 358–362. 56 indexed citations
20.
White, James D. & Scott C. Jeffrey. (1995). Synthesis of Bicyclo[3.3.1]nonanes via Manganese(III) Mediated Radical Cyclization of Olefinic β-Keto Esters. Synlett. 1995(8). 831–832. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martha E. Anderson Breakdown of academic impact, for papers by Robert P. Lyon Breakdown of academic impact, for papers by Roger F. Zabinski Breakdown of academic impact, for papers by Tim D. Bovee Breakdown of academic impact, for papers by Jamie B. Miyamoto Breakdown of academic impact, for papers by Brian A. Mendelsohn Breakdown of academic impact, for papers by Michael Torgov Breakdown of academic impact, for papers by Shang‐Fan Yu Breakdown of academic impact, for papers by Brian E. Toki Breakdown of academic impact, for papers by Janis Upeslacis
Rankless by CCL
2026